CD8:PA:PA-Amundi ETF MSCI EMU High Dividend UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 168.8

Change

+0.40 (+0.24)%

Market Cap

USD 0.22B

Volume

2.23K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.22 (-0.46%)

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-0.70 (-0.12%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+0.21 (+0.05%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

+0.04 (+0.10%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.54 (+0.60%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

N/A

USD 8.92B
WLD:PA Lyxor UCITS MSCI World D-EUR

+0.43 (+0.12%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

-0.06 (-0.10%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

N/A

USD 6.91B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+0.22 (+0.14%)

USD 5.17B

ETFs Containing CD8:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.12% 77% C+ 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.12% 77% C+ 71% C-
Trailing 12 Months  
Capital Gain 8.90% 42% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.90% 41% F 58% F
Trailing 5 Years  
Capital Gain 31.18% 47% F 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 31.18% 43% F 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 10.37% 60% D- 64% D
Dividend Return 10.37% 58% F 32% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.63% 57% F 42% F
Risk Adjusted Return 89.19% 66% D+ 43% F
Market Capitalization 0.22B 46% F 57% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.